271 related articles for article (PubMed ID: 32654213)
21. Attitudes toward pharmacogenetics in patients undergoing
Lee G; Varughese LA; Conway L; Stojinski C; Ashokkumar S; Monono K; Matthai W; Kolansky DM; Giri J; Tuteja S
Per Med; 2022 Mar; 19(2):93-101. PubMed ID: 34984913
[TBL] [Abstract][Full Text] [Related]
22. Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
Lemke AA; Hulick PJ; Wake DT; Wang C; Sereika AW; Yu KD; Glaser NS; Dunnenberger HM
Pharmacogenomics; 2018 Mar; 19(4):321-331. PubMed ID: 29469671
[TBL] [Abstract][Full Text] [Related]
23. Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing.
Haga SB; O'Daniel JM; Tindall GM; Mills R; Lipkus IM; Agans R
Clin Genet; 2012 Aug; 82(2):115-20. PubMed ID: 22283474
[TBL] [Abstract][Full Text] [Related]
24. Personal genome testing on physicians improves attitudes on pharmacogenomic approaches.
Lee KH; Min BJ; Kim JH
PLoS One; 2019; 14(3):e0213860. PubMed ID: 30921347
[TBL] [Abstract][Full Text] [Related]
25. Toward Integration of Pharmacogenomic Tests into Daily Clinical Practice: A General Survey for Polish Healthcare Workers.
Tafazoli A; Kitlas Golińska A; Mnich K; Amirabadizadeh A; Clark Marquez J; Miltyk W
Med Sci Monit; 2023 Jun; 29():e940119. PubMed ID: 37303136
[TBL] [Abstract][Full Text] [Related]
26. Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey.
Glewis S; Krishnasamy M; Lingaratnam S; Harris S; Underhill C; Georgiou C; Warren M; Campbell R; IJzerman M; Fagery M; Campbell I; Martin JH; Tie J; Alexander M; Michael M
Clin Transl Sci; 2023 Dec; 16(12):2700-2708. PubMed ID: 37877594
[TBL] [Abstract][Full Text] [Related]
27. Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.
Lau-Min KS; Varughese LA; Nelson MN; Cambareri C; Reddy NJ; Oyer RA; Teitelbaum UR; Tuteja S
BMC Cancer; 2022 Jan; 22(1):47. PubMed ID: 34996412
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives.
Bhatt M; Peshkin BN; Kazi S; Schwartz MD; Ashai N; Swain SM; Smith DM
Pharmacogenomics; 2023 Nov; 24(16):859-870. PubMed ID: 37942634
[No Abstract] [Full Text] [Related]
29. Interventional cardiologists' attitudes towards pharmacogenetic testing and impact on antiplatelet prescribing decisions.
Hoffecker G; Kanter GP; Xu Y; Matthai W; Kolansky DM; Giri J; Tuteja S
Per Med; 2022 Jan; 19(1):41-49. PubMed ID: 34881641
[TBL] [Abstract][Full Text] [Related]
30. A nationwide cross-sectional survey of pharmacy students on pharmacogenetic testing in The Netherlands.
Bank PC; Swen JJ; Guchelaar HJ
Pharmacogenomics; 2018 Mar; 19(4):311-319. PubMed ID: 29473451
[TBL] [Abstract][Full Text] [Related]
31. Assessing the impact of pre-test education on patient knowledge, perceptions, and expectations of pharmacogenomic testing to guide antidepressant use.
Sloat NT; Yashar BM; Ellingrod VL; Ward KM
J Genet Couns; 2022 Dec; 31(6):1373-1382. PubMed ID: 35900228
[TBL] [Abstract][Full Text] [Related]
32. Child and adolescent psychiatrists' use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice.
Soda T; Merner AR; Small BJ; Torgerson LN; Muñoz K; Austin J; Storch EA; Pereira S; Lázaro-Muñoz G
Psychiatry Res; 2023 Jul; 325():115246. PubMed ID: 37172398
[TBL] [Abstract][Full Text] [Related]
33. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
Pritchard D; Patel JN; Stephens LE; McLeod HL
Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
[TBL] [Abstract][Full Text] [Related]
34. Strategies and settings of clinical pharmacogenetic implementation: a scoping review of pharmacogenetics programs.
Luczak T; Brown SJ; Armbruster D; Hundertmark M; Brown J; Stenehjem D
Pharmacogenomics; 2021 Apr; 22(6):345-364. PubMed ID: 33829852
[TBL] [Abstract][Full Text] [Related]
35. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
[TBL] [Abstract][Full Text] [Related]
36. Comfort with Pharmacogenetic Testing Amongst Pediatric Oncology Providers and Their Patients.
Mowbray C; Turner J; Gai J; Jacobs S
J Pediatr Hematol Oncol Nurs; 2022; 39(3):168-177. PubMed ID: 35467433
[No Abstract] [Full Text] [Related]
37. Pharmacogenetic Information in Clinical Guidelines: The European Perspective.
Swen JJ; Nijenhuis M; van Rhenen M; de Boer-Veger NJ; Buunk AM; Houwink EJF; Mulder H; Rongen GA; van Schaik RHN; van der Weide J; Wilffert B; Deneer VHM; Guchelaar HJ;
Clin Pharmacol Ther; 2018 May; 103(5):795-801. PubMed ID: 29460273
[TBL] [Abstract][Full Text] [Related]
38. Attitudes about pharmacogenomic testing vary by healthcare specialty.
Preys CL; Blout Zawatsky CL; Massmann A; Heukelom JV; Green RC; Hajek C; Hickingbotham MR; Zoltick ES; Schultz A; Christensen KD
Pharmacogenomics; 2023 Jul; 24(10):539-549. PubMed ID: 37458095
[No Abstract] [Full Text] [Related]
39. Evaluation of a pharmacogenetic educational toolkit for community pharmacists.
Haga SB; Mills R; Moaddeb J
Pharmacogenomics; 2016 Sep; 17(14):1491-502. PubMed ID: 27533631
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenetic Testing Knowledge and Attitudes among Pediatric Psychiatrists and Pediatricians in Alberta, Canada.
Jessel CD; Al Maruf A; Oomen A; Arnold PD; Bousman CA
J Can Acad Child Adolesc Psychiatry; 2022 Feb; 31(1):18-27. PubMed ID: 35251193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
